Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Esteve patents voltage-dependent calcium channel subunit alpha2/delta-1 ligands

May 26, 2020

Clinical data for novel non-D2-receptor-binding compound in patients with schizophrenia

May 26, 2020

Atherosclerosis, AD meet at the myelin

May 26, 2020

Phase I/II data presented for LY-500307 in men with schizophrenia

May 25, 2020

GlaxoSmithKline plc synthesizes new H-PGDS inhibitors

May 25, 2020

Daiichi Sankyo presents new 5-HT2A receptor agonists

May 25, 2020

Final data show phase II study of ATL-1102 in DMD meets primary endpoint

May 22, 2020

FDA approves Kynmobi sublingual film to treat "off" episodes in Parkinson's disease

May 22, 2020

Esteve Pharmaceuticals synthesizes new analgesic drugs

May 22, 2020

Merck & Co. discloses muscarinic M4 receptor PAMs

May 22, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 22, 2026.
‘Detargeted’ targeted gene therapy improves activity in Pompe
BioWorld
A new strategy aims to improve gene therapy for Pompe disease by optimizing both the genetic component that restores the function of a deficient lysosomal enzyme...
News in brief
BioWorld Asia
BioWorld Asia briefs for May 19, 2026
Genescience presents STAT6 degrader for atopic dermatitis
BioWorld Science
Genescience Pharmaceutical Co. Ltd. has presented data on a new STAT6 PROTAC degrader – GenSciP166 – which selectively targets STAT6 for proteasomal degradation....
Roche reports new TREM2 agonists
BioWorld Science
F. Hoffmann-la Roche Ltd. and Hoffmann-La Roche Inc. have identified new triggering receptor expressed on myeloid cells 2 (TREM2) agonists potentially useful for...